21-hydroxylase deficiency MRI: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Aditya Ganti (talk | contribs) |
||
| Line 17: | Line 17: | ||
[[Category:Medicine]] | [[Category:Medicine]] | ||
[[Category:Up-To-Date]] | [[Category:Up-To-Date]] | ||
[[Category:Radiology]] | [[Category:Radiology]] | ||
Latest revision as of 15:33, 24 July 2020
|
21-hydroxylase deficiency Microchapters |
|
Differentiating 21-Hydroxylase Deficiency from other Diseases |
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
21-hydroxylase deficiency MRI On the Web |
|
American Roentgen Ray Society Images of 21-hydroxylase deficiency MRI |
|
Risk calculators and risk factors for 21-hydroxylase deficiency MRI |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mehrian Jafarizade, M.D [2]
Overview
On abdominal MRI, 21-hydroxylase deficiency is characterized by bilateral symmetric enlargement of the adrenal glands.
MRI Findings
On abdominal MRI, 21-hydroxylase deficiency is characterized by bilateral symmetric enlargement of the adrenal glands.[1]
Reference
- ↑ Agrons M, Jensen CT, Habra MA, Menias CO, Shaaban AM, Wagner-Bartak NA, Roman-Colon AM, Elsayes KM (2017). "Adrenal Cortical Hyperplasia: Diagnostic Workup, Subtypes, Imaging Features and Mimics". Br J Radiol: 20170330. doi:10.1259/bjr.20170330. PMID 28707538.